In one paragraphArticle in British journal of haematology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 94% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed, 0 citations in OpenAlex.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
8 authors at 4 institutions in 1 country.
Melissa C CaugheyJoint Department of Biomedical Engineering, University of North Carolina and North Carolina State University, Chapel Hill, North Carolina, USA.ORCID 0000-0001-8433-5147 Vimal K DerebailDivision of Nephrology and Hypertension, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.ORCID 0000-0002-7662-7497 Enrico M NovelliHeart, Lung, Blood, and Vascular Medicine Institute and Division of Hematology/Oncology, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.ORCID 0000-0003-3010-8285 Pamela L LutseyDivision of Epidemiology and Community Health, University of Minnesota, Minneapolis, Minnesota, USA.ORCID 0000-0002-1572-1340 Nigel S KeyDivision of Hematology and Blood Research Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.ORCID 0000-0002-8930-4304 Abhijit V KshirsagarDivision of Nephrology and Hypertension, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.ORCID 0000-0001-6669-7523 Gerardo HeissDepartment of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
University of North Carolina at Chapel Hill · USForma Therapeutics (United States) · USUniversity of Minnesota · USUniversity of Pittsburgh · US
Funding
Duke-UNC Clinical Hematology Research Career Development ProgramK12HL087097 · NHLBI · DUKE UNIVERSITY · PI TELEN, MARILYN J · 2006 to 2016
$4.0MPittsburgh Intensive Training in Hematology ResearchR25HL128640 · NHLBI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI NOVELLI, ENRICO M · 2015 to 2019
$382kNHLBI NIH HHS HHSN268201700001INHLBI NIH HHS HHSN268201700002INHLBI NIH HHS HHSN268201700003INHLBI NIH HHS HHSN268201700004INHLBI NIH HHS HHSN268201700005INHLBI NIH HHS K12 HL087097NHLBI NIH HHS R25 HL128640
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
AtherosclerosisSickle Cell TraitAdultCohort StudiesDehydrationHumansPrevalenceRisk Factorsadult dehydrationepidemiologysickle cell trait
Identifiers
PMID35510344
PMCPMC12951692
OpenAlexW4225373066
What OpenQuestion holds
Textmetadata
LicenceTDM
Read underepoch 390